BD

Barritault Denis

CEO

OTR3

Paris, Ile-de-France


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
OTR3
Industry
biotechnology
Employees
22.0
Seniority
C suite

Technologies

Outlook Microsoft Office 365 Apache reCAPTCHA WordPress.org Mobile Friendly Gravity Forms Google Font API Remote AI

Keywords

matrix therapy healing regenerating agents rgta chronic wounds corneal lesions cacipliq20 cacicol20 regenerative medicine ischemic stroke ards tissue regeneration rgta technology medical devices dermatological disorders neurological disorders heparan sulfate mimetics extracellular matrix clinical studies veterinary products biomaterials wound healing skin ulcers cellular micro-environment medical research iso 13485 certification product development biotech solutions cacipliq 20 clerapliq dermapliq cosmetics for athletes research & development stem cell therapy fibrosis treatment bioengineering surgical scars collagen restoration tissue repair scaffold restoration anti-fibrotic drugs pulmonary fibrosis preclinical studies human precision-cut lung slices skin tissue engineering chronic skin ulcers veterinary comfort products pharmaceutical industry post-market vigilance clinical operations matrix therapy agents advanced therapy medicinal products biopharmaceutical products regenerative agents subcontracting partnerships medical device production hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans